Introduction
As part of an ongoing medicinal chemistry programme to develop synthetically accessible and modifiable scaffolds [1, 2, 3] , the facile S N Ar reaction of perfluoroarenes [4] is being employed to generate fluorinated heterocyclic libraries [5] for screening. S N Ar reactions of perfluorinated aromatics occur predictably with a wide range of nucleophiles, proceed readily under mild conditions, and without the need for transition metal catalysis [6] . Substitution patterns available by stepwise replacement of fluorines are different from those afforded by electrophilic aromatic substitution and allow preparation of diverse structural types [7, 8] . Potential for ring formation with bidentate nucleophiles [9, 10] , control of regiochemistry through hard/soft nucleophilic interactions [11, 12,] , and alternative methods for promoting reaction by ultrasound [13] continue to attract attention. Retaining fluorine in a molecule is also desirable from a medicinal chemistry perspective, since fluorine can improve resistance to metabolism due to the strong C-F bond (485 kJmol -1 ) while the small size (van der Waals radius, 1.47 Å) and high electronegativity (3.98 Pauling scale) endow specific electronic properties that can dramatically alter the biological response of the compound [14, 15] . Benzimidazoles, amongst other aza-heterocycles, represent privileged substructures in medicinal chemistry and serve as desirable building blocks in the design and construction of bioactive compounds [16, 17, 18] . Here we report the synthesis of a number of N-fluoroaryl benzimidazole derivatives using S N Ar substitution of perfluorinated arenes and the screening of these for activity against breast carcinoma MCF-7, leukemia K562, melanoma G361
and osteosarcoma HOS cell lines. The structures of the fluoroaryl benzimidazole derivatives prepared were confirmed by NMR spectroscopy and X-ray crystallographic analysis.
Results and Discussion

Heterocyclic Synthesis and Characterisation
Benzimidazole [19, 20, 21] and related azoles [22, 23] are known to add to pentafluoropyridine and the aim of this work was to exploit the ready S N Ar reaction of benzimidazole derivatives with pentafluoropyridine as a building block to make composite linked and fused heterocyclic scaffolds.
Furthermore, these scaffolds would have potential for further modification to allow synthesis of diverse libraries of molecules that can be screened for biological activity. Continuing our interest in preparing condensed polycyclic heterarenes from perfluoroarenes [24] we first explored the reaction of pentafluoropyridine 2 with 1,3-dihydro-2H-benzimidazole-2-thione 1 (Scheme 1), expecting to obtain the tetracylic-fused thiazole 3 by a tandem S N Ar addition. The thiolate group of the anion of 1 was expected to be the most nucleophilic centre and likely to attack C-4 of pentafluoropyridine first, leading to the ring fusion shown in 3, if the ring nitrogen then effected a second substitution.
Similar condensations with aminopyridines to form imidazopyridines have been reported [25] . We found however that the thione 1, on treatment with sodium hydride in DMF, reacted instead with two molecules of pentafluoropyridine to give the di-arylated benzimidazole 4 in which both the sulfur atom and a ring nitrogen of 1 had added to the 4-position of separate pentafluoropyridine molecules. Compound 4 was formed even when one equivalent of pentafluoropyridine was used, and the best yield of 4 was obtained with three equivalents. Sodium hydride is a convenient base for these reactions and can be pre-mixed with the fluoroarene prior to addition of the nucleophile. It allows rapid, quantitative deprotonation of the NH group of heterocyclic nucleophiles. The structure of compound 4 was supported by 19 F-NMR spectroscopy, which exhibited four signals of equal intensity (AA'BB'CC'DD' system) consistent with four pairs of fluorine atoms, rather than three signals expected for tetracycle 3. Confirmation of the structure was obtained by single crystal X-ray diffraction analysis, and the molecular structure is shown in Figure 1 [26; crystal data in Table 3 ].
Addition of pentafluoropyridine to both ring nitrogen and exocyclic amine groups has also been observed with 2-aminopyridine derivatives [27] . as a nucleophilic partner to add to pentafluoropyridine to form tethered heterocyclic scaffolds, as linked compounds [29] were of interest due to their potential for acting as bis-intercalating [30, 31] and cross linking agents [32, 33, 34] for DNA binding. The bis-benzimidazole 5 (Scheme 2) (X-ray structure shown in Figure 2) , with a four-methylene spacer chain, reacted readily with excess pentafluoropyridine 2, in the presence of sodium hydride, to form 6. adding para to the ester groups which represent sites for further derivatisation. The X-ray crystal structure of the ester compound 9 is shown in Figure 5 . A further scaffold (Scheme 3) containing tethered benzimidazole units was readily prepared by reaction of pentafluorobenzoyl chloride with 2,2'-(ethylenedioxy)bis(ethylamine) forming bisamide 10. Reaction with the anion of benzimidazole 11 generated with sodium hydride led to substitution of the para fluorine atom in each pentafluorobenzamide ring, affording scaffold 12.
The structure was confirmed by 1 H and 19 F NMR spectroscopy. X-ray crystallography was also used to confirm the structure of the tethered pentafluorobenzamide 10 ( Figure 7 ). Diffraction data for 10 required synchrotron radiation due to small crystal size. MHz (for 1 H) NMR spectrometer ensuring that sufficient data points were acquired in the FID with sufficient signal-to-noise to allow resolution-enhancement by application of a Gaussian function.
(estimated). Analysis of the 13 C- 19 F couplings in 4 is given in the supplementary information.
The ease of such S N Ar reactions with a range of benzimidazole nucleophiles demonstrates that this synthetic approach can be utilised to rapidly generate libraries of compounds with latent functionality for biological screening. The composite heterocycles prepared were then examined for anti-cancer activity to identify scaffolds that could be further refined into potential drug candidates.
Anticancer activity in vitro
The anticancer activities of all new compounds were determined against several breast carcinoma MCF-7 and leukemia K562 cell lines after 72 h of incubation using the Calcein assay, and the CDK inhibitor, roscovitine, as a control compound. The results obtained ( These four compounds were further screened against melanoma G361 and osteosarcoma HOS cell lines to expand information about selectivity towards various types of cancers ( Table 2 ). Concentration-dependent activity was observed in all cases with these four Flow cytometric analysis revealed that some compounds increase sub-G1 population, which is a well accepted indicator of ongoing apoptotic cell death. We therefore analyzed treated K562 cells for activity of caspases 3 and 7, proteases that are activated during apoptotic cell death. Figure 9 shows the results of biochemical assay of caspase 3/7 activity in cells treated for 24 h with the studied compounds at doses corresponding to 1× and 3× IC 50 values. While 7d was inactive in the assay, compounds 6 and 8a significantly stimulated activation of the caspases, with the increase in activity more than twenty-fold, and five-fold, over untreated control cells respectively. Based on flow cytometric results and biochemical assay of caspases we conclude that 6 and 8a induce apoptosis in treated cells. However, the flow cytometric experiments suggest that the active compounds exhibit their toxicity through different cellular targets. Further work is ongoing to identify the mode of action of these fluorinated compounds. were lysed and the activities of caspases were measured using the fluorogenic substrate Ac-DEVD-AMC and normalised to untreated control.
Conclusion
A library of twelve, structurally diverse, fluoroaryl benzimidazoles was prepared using a simple These compounds, in addition to 4, also demonstrated micromolar inhibition against G361 and HOS cell lines. Compounds 6 and 8a were found to activate caspases leading to apoptosis.
Experimental
General Methods
All reactions were conducted under anhydrous conditions using oven/flame-dried glassware under a nitrogen atmosphere. Commercially available solvents were used without further purification, except THF, which was distilled from sodium and benzophenone. DMF and DMSO were purchased dry from a commercial supplier. Light petroleum refers to the fraction boiling between 40-60 °C.
NMR spectra were recorded ( 1 H, 19 F and 13 C) using Bruker 500 and 400 MHz, or Jeol ECS-400 instruments with tetramethylsilane as internal standard or hexafluorobenzene for 19 F spectra.
Chemical shifts are reported in ppm and coupling constants are recorded in hertz. 1 H spectra were recorded at 400 MHz, 19 F spectra at 376 MHz and 13 C spectra were recorded at 125 or 100 MHz.
DEPT was used to assign environment (CH, CH 2 , CH 3 ) in 13 C NMR spectra. The solvent is specified in brackets. A Thermofisher Exactive (orbitrap) mass spectrometer was used to obtain high-resolution mass spectra, with ESI as the ionization mode. The solvent used for all samples was methanol. Other high-resolution mass spectra were recorded at the EPSRC UK National Mass Spectrometry Facility.
GC-MS was performed on a Fisons 8060 with a DB5MS column of 30 m length and split-less injection.
A Perkin-Elmer spectrum 65FT-IR spectrophotometer was used to obtain infrared spectra. Liquid samples were acquired as thin films on NaCl. Solid samples were acquired as KBr discs.
Melting points were recorded using an Electro thermal-IA 9100 melting point instrument.
TLC analysis was carried out on Merck TLC silica gel 60 F 254 aluminum backed plates and were visualised under UV light at 254 nm or by vanillin stain. Column chromatography was carried out on Merck Kiesel 60 silica gel.
Elemental analysis was determined using a Perkin-Elmer 2400 analyser.
1-Tetrafluoropyrid-4-yl-2-tetrafluoropyrid-4-ylsulfanyl-1H-benzimidazole 4
A solution of pentafluoropyridine (1.01 g, 6 mmol) in DMF (1.5 mL) was added to NaH (60% dispersion in mineral oil) (0.16 g, 4 mmol) and the mixture treated dropwise with a solution of 2-mercaptobenzimidazole (0.30 g, 2 mmol) in DMF (1.5 mL). The mixture was shaken until gas evolution ceased and was then maintained at room temperature for 18 h. The reaction mixture was partitioned between ether (25 mL) and water (10 mL). The ether layer was separated, washed with water (2 × 2 mL) and saturated NaCl (aq) (2 mL), dried over MgSO 4 
2,2'-(Ethylenedioxy)-bis-ethyl 4-benzimidazol-1-yltetrafluorobenzamide 12
A solution of benzimidazole (0.236 g, 2 mmol) in THF (3 mL) was added dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.08 g, 2 mmol) in THF (3 mL). After 30 min a solution of 10 (0.536 g 1 mmol) in THF (3 mL) was added dropwise. 
Cell Cultures
Human cancer cell lines MCF-7, K562, G361 and HOS (purchased from the American Type Culture Collection) were maintained in DMEM supplemented with 10% fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 μg/ml). All cell lines were cultivated at 37 °C in 5% CO 2 as described previously [39, 40] .
Cytotoxicity Assays
The cytotoxicity of the studied compounds was determined as described previously [39, 40] .
Briefly, cells were assayed with compounds using three-fold dilutions in triplicate. 
Caspase activity assay
The cells were homogenised in an extraction buffer (10 mM KCl, 5 mM HEPES, 1 mM EDTA, 1 mM EGTA, 0.2% CHAPS, inhibitors of proteases, pH 7.4) on ice for 20 min. The homogenates were clarified by centrifugation at 10000 × g for 30 min at 4 ºC, and then the proteins were quantified and diluted to equal concentrations. Lysates were then incubated for 3 h with 100 µM Ac-DEVD-AMC as a substrate of caspases 3 and 7 in the assay buffer (25 mM PIPES, 2 mM EGTA, 2 mM MgCl 2 , 5 mM DTT, pH 7.3). The fluorescence of the product was measured using a Fluoroskan Ascent microplate reader (Labsystems) at 355/460 nm (excitation/emission) as described previously [39, 40] . 
